Alberto Bavelloni
Bologna, 40136, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
The Emerging Role and Clinical Significance of PI3K-Akt-mTOR in Rhabdomyosarcoma.
Journal: Biomolecules
Published: January 29, 2025
Genomic profiling of a collection of patient-derived xenografts and cell lines identified ixabepilone as an active drug against chemo-resistant osteosarcoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 29, 2025
ANKRD2 Knockdown as a Therapeutic Strategy in Osteosarcoma: Effects on Proliferation and Drug Response in U2OS and HOS Cells.
Journal: International journal of molecular sciences
Published: January 28, 2025
Phospholipase Cδ-4 (PLCδ4) Acts as a Nuclear Player to Influence Cyclin B Expression in the Embryonal Rhabdomyosarcoma Cell Lines RD and A204.
Journal: Biomolecules
Published: July 19, 2024
Morpho-Functional Analyses Demonstrate That Tyrosol Rescues Dexamethasone-Induced Muscle Atrophy.
Journal: Journal of functional morphology and kinesiology
Published: May 13, 2024
Molecular characterization of ANKRD1 in rhabdomyosarcoma cell lines: expression, localization, and proteasomal degradation.
Journal: Histochemistry and cell biology
Published: February 11, 2024
Alternative Splicing, RNA Editing, and the Current Limits of Next Generation Sequencing.
Journal: Genes
Published: June 08, 2023
Antitumor activity of natural pigment violacein against osteosarcoma and rhabdomyosarcoma cell lines.
Journal: Journal of cancer research and clinical oncology
Published: March 28, 2023
The Cytotoxic Effect of Curcumin in Rhabdomyosarcoma Is Associated with the Modulation of AMPK, AKT/mTOR, STAT, and p53 Signaling.
Journal: Nutrients
Published: December 22, 2022
Last Updated: 09/26/2026